Abpro Holdings Inc. (ABPO) vs Artelo Biosciences, Inc. (ARTL)

Abpro Holdings Inc. and Artelo Biosciences, Inc. are both Biotechnology companies. Abpro Holdings Inc. and Artelo Biosciences, Inc. are of similar size ($1.5M and $1.4M). Artelo Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.2×. Across the 9 metrics below, Abpro Holdings Inc. leads on 7 and Artelo Biosciences, Inc. on 2.

Valuation

Metric ABPO ARTL Biotechnology median
P/E 0.20 n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.16 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 0.31 0.64
EV/Sales n/m n/m 9.21
Earnings yield 500.00% (4,348.52%) (33.15%)
Free cash flow yield (311.42%) (1,553.13%) (25.50%)

Profitability

Metric ABPO ARTL Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) (705.71%) (56.36%)
Return on assets 46.10% (234.30%) (48.04%)
Return on invested capital 0.00% (865.85%) 0.00%

Growth

Metric ABPO ARTL Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 94.15% 31.57% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO ARTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 3.00 4.72
Net debt to EBITDA 0.01 0.05 0.96

Dividend

Metric ABPO ARTL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABPO ARTL Biotechnology median
Market cap 1.42m 1.50m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack